MedTrace Logo

HPV Integration Testing for Cervical Cancer Screening

NCT02576158 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2017-06-27

No results posted yet for this study

Summary

The primary objective is to determine the sensitivity and specificity of the HPV Integration-based cervical screening for detection of high-grade cervical intraepithelial neoplasia (CIN), using colposcopic inspection as the reference method. Lesions will be confirmed as malignant or CIN by colposcopic inspection and histopathologic examination.

Conditions

Interventions

PROCEDURE

TCT，HPV，colposcopic inspection

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Ding Ma, MD, PhD · Huazhong University of Science and Technology

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-09-30
Completion
2020-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576158 on ClinicalTrials.gov